Brief: Proteomics International Laboratories Signs Exclusive LOI With Sonic Healthcare U.S.
Aug 9 (Reuters) - Proteomics International Laboratories Ltd
PIQ.AX :
* SIGNED A BINDING AND EXCLUSIVE LETTER OF INTENT WITH SONIC
HEALTHCARE USA
* LOI FOR EXCLUSIVE LICENCE FOR USE OF CO'S PROMARKERD TEST
FOR
DIABETIC KIDNEY DISEASE IN U.S
Source text for Eikon: ID:nASX5G5CYb
Further company coverage: PIQ.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Proteomics International Laboratories
See all newsBrief: Proteomics International Laboratories Launches Share Purchase Plan To Raise Up To A$5 MLN
Australia's Proteomics slips to four-month low on discounted share sale plan
Brief: Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million
Brief: Proteomics International Laboratories Signs Agreement With Healius For Promarker Portfolio
Australia's Proteomics International soars on distribution deal with Healius